Latest News

Basierend auf der Datenbank des Web of Science hat das Laborjournal (10/2014) für die Jahre 2008-2012 eine Publikationsanalyse zur Kategorie „Cardiac and Cardiovascular Systems“ durchgeführt. Das Ergebnis ist erfreulich: Insgesamt gehören im besagten Zeitraum 17 DZHK-PI und drei...

The impact of the environment on our genetic makeup has long been a topic of discussion among researchers. Now a European consortium (EURATRANS) headed by DZHK-PI Professor Norbert Hübner of the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch has taken the opposite...

They are doctors, scientists and science managers - and the participants of the DZHK Mentoring Programme, which was launched in early March with a three-day workshop. The programme's goal is to get junior cardiovascular researchers ready for taking on leadership roles. It...

Starting with a severely affected family, a research team led by Jeanette Erdmann, Christian Hengstenberg and Heribert Schunkert (Institut für Integrative und Experimentelle Genomik, University of Lübeck and Deutsches Herzzentrum München) identified a novel mechanism leading to...

An international team of scientists, among them scientists of the DZHK, discovered an important fundamental process in hearts from patients with advanced heart failure, allowing a better understanding of the origin of this disease. Previously, it was already noted that...

Start for Europe-wide and only fully publicly funded ICD- patient study EU CERT ICD with significant participation of DZHK partners: UMG heart center coordinates.

Up to this point, implantable cardioverter defibrillators (ICD) were considered a life insurance against sudden...

The company Boehringer Ingelheim is continuing its support for the Gutenberg Health Study (GHS) with a sum of three million Euros by the end of 2017. Thereby, the GHS which started in 2007 is backed up until the end of that year. The aim is to build a biobank based on the data...

Göttingen pharmacologists led by DZHK - scientist Prof. Dr. Ali El - Armouche explore new therapy for heart failure: they activate the heart’s self-protection systems through targeted stimulation.

Currently, there is no therapy for myocardial weakness that can stop the...